Statutory Instrument 1996 No. 1300

The Misuse of Drugs Act 1971 (Modification) Order 1996

---

© Crown Copyright 1996

Statutory Instruments printed from this website are printed under the superintendence and authority of the Controller of HMSO being the Queen's Printer of Acts of Parliament.

The legislation contained on this web site is subject to Crown Copyright protection. It may be reproduced free of charge provided that it is reproduced accurately and that the source and copyright status of the material is made evident to users.

It should be noted that the right to reproduce the text of Statutory Instruments does not extend to the Queen's Printer imprints which should be removed from any copies of the Statutory Instrument which are issued or made available to the public. This includes reproduction of the Statutory Instrument on the Internet and on intranet sites. The Royal Arms may be reproduced only where they are an integral part of the original document.

The text of this Internet version of the Statutory Instrument which is published by the Queen's Printer of Acts of Parliament has been prepared to reflect the text as it was Made. A print version is also available and is published by The Stationery Office Limited as the The Misuse of Drugs Act 1971 (Modification) Order 1996, ISBN 0110547217. The print version may be purchased by clicking here. Braille copies of this Statutory Instrument can also be purchased at the same price as the print edition by contacting TSO Customer Services on 0870 600 5522 or e-mail:customer.services@tso.co.uk.

Further information about the publication of legislation on this website can be found by referring to the Frequently Asked Questions.

To ensure fast access over slow connections, large documents have been segmented into "chunks". Where you see a "continue" button at the bottom of the page of text, this indicates that there is another chunk of text available.

1996 No. 1300

DANGEROUS DRUGS

The Misuse of Drugs Act 1971 (Modification) Order 1996

At the Court at Buckingham Palace, the 15th day of May 1996

Present,

The Queen's Most Excellent Majesty in Council

Whereas a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and has been approved by a resolution of each House of Parliament:

Now, therefore, Her Majesty, in pursuance of section 2(2) of the Misuse of Drugs Act 1971^[1], is pleased, by and with the advice of Her Privy Council, to order, and it is hereby ordered, as follows:

    1.    This Order may be cited as the Misuse of Drugs Act 1971 (Modification) Order 1996 and shall come into force on 1st September 1996.

    2.—(1)  Schedule 2 to the Misuse of Drugs Act 1971^[2] (which specifies the drugs which are subject to control under that Act) shall be amended as follows.

    (2)  In paragraph 1 of Part III of that Schedule
 (a) the list of substances and products beginning with"Alprazolam"and ending with "Triazolam"shall be designated sub-paragraph (a), and accordingly "(a)"shall be inserted before "Alprazolam"; and
 (b) there shall be added at the end the following sub-paragraphs —
"(b) Atamestane.

Bolandiol.

Bolasterone.

Bolazine.

Boldenone.

Bolenol.

Bolmantalate.

Calusterone.

4-Chloromethandienone.

Clostebol.

Drostanolone.

Enestebol.

Epitiostanol.

Ethyloestrenol.

Fluoxymesterone.

Formebolone.

Furazabol.

Mebolazine.

Mepitiostane.

Mesabolone.

Mestanolone.

Mesterolone.

Methandienone.

Methandriol.

Methenolone.

Methyltestosterone.

Metribolone.

Mibolerone.

Nandrolone.

Norboletone.

Norclostebol.

Norethandrolone.

Ovandrotone.

Oxabolone.

Oxandrolone.

Oxymesterone.

Oxymetholone.

Prasterone.

Propetandrol.

Quinbolone.

Roxibolone.

Silandrone.

Stanolone.

Stanozolol.

Stenbolone.

Testosterone.

Thiomesterone.

Trenbolone.

(c) any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,
(i) by further substitution at position 17 by a methyl or ethyl group;

(ii) by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;

(iii) by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;

(iv) by fusion of ring A with a heterocyclic system;

(d) any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above;

(e) Chorionic Gonadotrophin (HCG).

Clenbuterol.

Non-human chorionic gonadotrophin.

Somatotropin.

Somatrem.

Somatropin." .

N. H. Nicholls

Clerk of the Privy Council

This Order adds to Part III of Schedule 2 to the Misuse of Drugs Act 1971 (which specifies the Class C drugs which are subject to control under the Act) the anabolic and androgenic steroids and derivatives; an andrenoceptor stimulant; and polypeptide hormones specified in article 2(2)(b).

[1] 1971 c. 38. back

[2] Schedule 2 has been amended by S.I. 1973/771, 1975/421, 1977/1243, 1979/299, 1983/765, 1984/859, 1985/1995, 1986/2230, 1989/1340, 1990/2589 and 1995/1966. back